Dapagliflozin/Saxagliptin Fixed-Dose Tablets: A New Sodium-Glucose Cotransporter 2 and Dipeptidyl Peptidase 4 Combination for the Treatment of Type 2 Diabetes

Overview of attention for article published in Annals of Pharmacotherapy, September 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 797 followers.

Dapagliflozin/saxagliptin: an option for patients with T2DM not controlled on metformin - Annals of Pharmacotherapy https://t.co/AVmuSNqzIy

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.